网站地图 | 联系我们

您当前位置:首页
Wuhan Centers For Disease Prevention & Control

ABOUT US

中心简介

基本情况

刘满清,病原生物检验所副所长,硕士,副主任技师,现任中国微生物学会临床微生物专业委员会青年委员兼流行病学组副组长、湖北省预防医学会微生态专业委员会青年副主任委员、华中科技大学同济医学院公共卫生学院兼职副教授、国家自然科学基金评审专家、武汉市应急管理专家、武汉市临床检验质量控制中心专家、《JClin Transl Hepatol》杂志编委、frontiers in Medicine/Public Health杂志Review Editor、《Clinical Microbiology and Infection》等SCI杂志审稿人。

  • 业务专长

    主要研究方向为病毒性疾病的分子诊断。

    主持完成的项目课题有:

    新型冠状病毒感染临床严重程度的病原和宿主因素分析,武汉市科学技术局新型冠状病毒感染的肺炎应急技术攻关专项(No:2020020101010008),2020;

    microRNA作为HIV急性感染潜在生物标志物的研究,湖北省卫生健康委员会面上项目(No:WJ2019M014),2019-2020;

    HIV/AIDS病人PBMC中HIV/HCV相关miRNAs表达水平研究,病毒学国家重点实验室2014年度开放课题(No:2014KF002),2014-2016;

    艾滋病人外周血中IFN-λ的表达水平与艾滋病程进展的相关性研究,国家自然科学基金(No: 81001303),2011-2013 .

  • 荣誉与奖励

    获2020年度享受市政府专项津贴;

    2013年入选武汉市青年医学骨干人才;

    主持完成的《武汉地区星状病毒分子流行病学研究》课题先后获武汉市科技进步二等奖、湖北省科技进步三等奖、湖北省预防医学科学技术二等奖;

  • 主要论文和著作

    1.Zhou JB, Kong WH, Wang S, Long YB, Dong LH, He ZY, Liu MQ*. Detection of SARS-CoV-2 RNA in medical wasterwater in Wuhan during the COVID-19 outbreak. Virologica Sinica 2021.https://doi.org/10.1007/s12250-021-00373-z.

    2.Liu P, Tang L, Kong WH, Zhu ZR, Xiao P, Wang X, Zhou W, Liu MQ*. Anti-HIV-1 antibodies based confirmatory results in Wuhan, China, 2012-2018. PLoS One 2020;15(9):e0238282.

    3.Kong WH, Zhao R, Zhou JB, Wang F, Kong DG, Sun JB, Ruan QF, Liu MQ*. Serologic response to SARS-CoV-2 in COVID-19 patients with different severity. Virologica Sinica 2020;35(6):752-757.

    4.Kong WH, Li Y, Peng MW, Kong DG, Yang XB, Wang L, Liu MQ*. SARS-CoV-2 detection in patients with influenza-like illness. Nat Microbiol 2020;5:675-8.

    5.Kong WH, Liu P, Tang L, Zhu ZR, Xiao P, Zhan JB, Wang X, Zhou W, Liu MQ*. Estimation of seroconversion duration of HIV-1 antibodies in individuals with recent infection in China. Front Microbiol 2019;10:1322.

    6.Liu MQ,Zhao M, Kong WH, Tang L, Wang F, Zhu ZR, Wang X, Qiu HY, Zhou DJ, Wang X, Ho WZ, Zhou W. Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway. Oncotarget 2017;8:22524-33.

    7.Liu MQ,Zhu ZR, Kong WH, Tang L, Peng JS, Wang X, Xu J, Schilling RF, Cai T, Zhou W.High rate of missed HIV infections in individuals with indeterminate or negative HIV western blots based on current HIV testing algorithm in China. J Med Virol 2016;88:1462-6.

    8.Fang Y#, Liu MQ#, Chen L, Zhu ZG, Zhu ZR, Hu Q.Rabies post-exposure prophylaxis for a child with severe allergic reaction to rabies vaccine. Hum Vaccin Immunother 2016;12(7):1802-4.

    9.Liu MQ, Zhao M, Kong WH, Peng JS, Wang F, Qiu HY, Zhu ZR, Tang L, Sang M, Wu JG, Ho WZ, Zhou W.Antiretroviral Therapy Fails to Restore Levels of HIV-1 Restriction miRNAs in PBMCs of HIV-1-infected MSM. Medicine 2015;94(46):e2116.

    10.Hu Q#, Liu MQ#, Zhu ZG, Zhu ZR, Lu S.Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China. Hum Vaccin Immunother 2014;10(6): 1645-9.

    11.Liu MQ,Tang L, Kong WH, Zhu ZR, Peng JS, Wang X, Yao ZZ, Schilling R, Zhou W. CD4+ T cell count, HIV-1 viral loads and demographic variables of newly identified patients with HIV infection in Wuhan, China. JMed Virol 2013;85(10):1687-91.

    12.Liu MQ, Zhou DJ, Wang X, Zhou W, Ye L, Li JL, Wang YZ, Ho WZ. IFN-λ3 inhibitsHIV infection of macrophagesthrough theJAK-STATpathway. PLoS One 2012;7(4):e35902.

    13.Wang F, Wang YH, Peng JS, Zhou X, Tang L, Kobayashi N, Hu Q, Zhou DJ, Huang HJ, Liu MQ*. Genetic characterization of Human astrovirus infection in Wuhan, People's Republic of China, 2007-2008. Can J Microbiol 2011;57:964-8.

    14.Liu MQ,Peng JS, Tang L, Zhou Y, Yang BF, Wang YH, Wang B, Zhou DJ, Huang HJ, Ho WZ. Identification of new subtype of astrovirus type 3 from an infant with diarrhea in Wuhan, China. Virology 2008;375(1):301-6.

    15.Liu MQ,Yang BF, Peng JS, Zhou DJ, Tang L, Wang B, Liu Y, Sun SH, Ho WZ. Molecular epidemiology of astrovirus infection in infants in Wuhan, China. JClin Microbiol 2007;45(4):1308-9.